Syndromic gastrointestinal stromal tumors

Area of Science:

• Gastroenterology
• Oncology
• Genetics

Background:

• Gastrointestinal stromal tumors (GISTs) are the most common gastrointestinal mesenchymal neoplasms.
• Most GISTs are sporadic, but some arise from heritable GIST-predisposing syndromes.
• Syndromic GISTs require specific diagnostic, prognostic, and therapeutic approaches.

Purpose of the Study:

• To review the diagnostic, prognostic, and therapeutic implications of GIST-predisposing syndromes.
• To aid clinicians in managing these rare conditions.

Main Methods:

• Literature review focusing on GIST-prone syndromes.
• Analysis of clinical, molecular, and genetic features.
• Discussion of diagnostic criteria and management strategies.

Main Results:

• GIST-prone syndromes present with unique clinical features, often involving multiple tumors or associated symptoms.
• Genotyping can confirm underlying genetic defects.
• Prognosis is influenced by both GIST characteristics and the specific syndrome.

Conclusions:

• Early identification of GIST-predisposing syndromes is essential for personalized patient care.
• Management involves complex decisions regarding preventive and targeted therapies.
• Further guidelines are needed for comprehensive management.